← SynDRA
PRELADENANT
SynDRA canonical compound SYN0007822 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | ADORA2A |
|---|
| Mechanism of action | Adenosine receptor antagonist |
|---|
All known targets
- ADORA2A
- ADORA1
- ADORA2B
- ADORA3
Mechanisms of action (all sources)
- Adenosine receptor antagonist
- ADORA2A ANTAGONIST
- Adenosine A2a receptor antagonist
- ADORA1 ANTAGONIST
- ADORA2B ANTAGONIST
- ADORA3 ANTAGONIST
Cross-references
Synonyms
- SCH-420814
- MK-3814
- Sch 420814
- SCH420814
- preladenantum
- RefChem:868474
- DTXCID50113710
- UNII-950O97NUPO
- MFCD17167056
- Preladenant [USAN:INN]
- C25H29N9O3
- PRELADENANT [INN]
- Preladenant (USAN/INN)
- PRELADENANT [USAN]
- Preladenant(SCH420814)
- PRELADENANT [WHO-DD]
- Preladenant(SCH420814)?
- GTPL5614
- orb1302982
- SCHEMBL2856554
- GLXC-07617
- EX-A1325
- BDBM50202986
- s6910
- AKOS016006028
- CS-0999
- FP27156
- SB36921
- NCGC00378857-01
- NCGC00378857-02
- AC-28199
- DA-42600
- DS-14327
- HY-10889
- SY031359
- NS00072631
- T4290
- D09717
Look up PRELADENANT in the interactive SynDRA portal →